Carcinoid tumor and bone metastases: Diagnosis by somatostatin receptor scintigraphy;Tumor carcinoide y metástasis óseas: Diagnóstico mediante gammagrafía de receptores de somatostatina

Revista Espanola de Medicina Nuclear

Volumn 23, Issue 6, 2004, Pages 394-402

  Banzo, J ^a   Abos M D ^a   Prats, E ^a   Razola, P ^a   Garcia S ^b   Alonso, V ^b   Velilla, J ^b   Garcia F ^a   Ubieto, M A ^a   Tardin L ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

111In DTPAOC; Bone metastases; Carcinoid tumor; Somatostatin receptor scintigraphy

Indexed keywords

SOMATOSTATIN RECEPTOR; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER STAGING; CARCINOID; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; WHOLE BODY SCINTISCANNING;

EID: 20844452201     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1157/13067825     Document Type: Article

References (32)

1. Kulke MH, Mayer RJ. Carcinoid tumors. Lancet 1999;340:858-68.
2. Jensen RT. Carcinoid and pancreatic endocrine tumors: recent advances in molecular pathogenesis, localization, and treatment. Curr Opin Oncol 2000;12:368-77.
3. Reubi JC. Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging. J Nucl Med 1995;36:1825-35.
4. Ricke J, Klose KJ. Imaging procedures in neuroendocrine tumours. Digestion 2000;62(supl 1):39-44.
5. Slooter GD, Mearadji A, Breeman WAP, Marquet RL, de Jong M, Krenning EP, et al. Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours. Br J Surg 2001;88:31-40.
6. Lebtahi R, Cadiot G, Sarda L, Daou D, Faraggi M, Petegnief Y, et al. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med 1997;38:853-8.
7. Jamar F, Fiasse R, Leners N, Pauwels S. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. J Nucl Med 1995;36:542-49.
8. 123I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease. Nucl Med Commun 2002;23: 733-41.
9. Meijer WC, van der Veer E, Jager OL, van der Jagt EJ, Piers BA, Kema IP, et al. Bone metastases in carcinoid tumors: Clinical features, imaging characteristic, and markers of bone metabolism. J Nucl Med 2003;44:184-91.
10. Mignon M. Natural history of neuroendocrine enteropancreatic tumors. Digestion 2000;62(supl 1):51-8.
11. Sandor A, Modlin IM. A retrospective analysis of 1570 appendiceal carcinoids. AJG 1998;93:422-28.
12. Soga J, Yakuwa Y. Bronchopulmonary carcinoids: An analysis of 1875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg 1999;5:211-9.
13. Janson ET, Holmberg L, Stridsberg M, Eriksson B, Theodorsson E, Wilander E, et al. Carcinoids tumors: Analysis of prognostic factors and survival in 301 patients a referral center. Ann Oncol 1997;8:685-90.
14. McDermott EWM, Guduric B, Brennan MF. Prognostic variables in patients with gastrointestinal carcinoid tumours. Br J Surg 1994;81:1007-9.
15. Soga J. Carcinoids of the small intestine: A statistical evaluation of 1102 cases collected from literature. J Exp Clin Cancer Res 1997;16:353-63.
16. Soga J. Carcinoids of the colon and ileocecal region: A statistical evaluation of 363 cases collected from the literature. J Exp Clin Res 1998;17:137-47.
17. Ross EM, Roberts WC. The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med 1985;79:339-54.
18. Pederson RT, Haldak DJ, Ferris RA, Macdonald JS, Schein PS. Osteoblastic bone metastasis in Zolliger-Ellison syndrome. Radiology 1976;118:63-4.
19. Powell JM. Metastatic carcinoid of bone. Report of two cases and review of the literature. Clin Orthop 1988;230:266-72.
20. McAdams HP, McElaney B, Erasmus J. Chest case of the day. AJR 1995;165:186-7
21. Peavy PW, Rogers JV, Clements JL, Burns B. Unusual osteoblastic metastases from carcinoid tumors. Radiology 1973; 107:327-30.
22. Merle-Vincent F, Chevrel G, Lombard-Bohas C, Felmann C, Meunier PJ. Métastases osseuses des tumeurs carcinoïdes bronchiques: a propos de deux observations. Rev Rhum (Ed. Fr.) 1999;66:49-51.
23. Frilling A, Malago M, Martin H, Broelsch CE. Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors. Surgery 1998;124:1000-4.
24. Fuster D, Navasa M, Pons F, Vidal-Sicart S, Mateos JJ, Lomeña F, et al. In-111 octreotide scan in a case a neuroendocrine tumor of unknown origin. Clin Nucl Med 1999;24:955-8.
25. Banzo J, Abós MD, Prats E, García F, Freile E, Razola P, et al. Tumor carcinoide bronquial y gammagrafía de receptores de somatostatina: detección de metástasis óseas. Rev Esp Med Nucl 2001;20:74-81.
26. Savelli G, Chiti A, Spinelli A, Regalia E, Mazzaferro V, Castellani MR, et al. Bone lesion in a patient with transplanted liver for a metastatic carcinoid. The role of somatostatin receptor scintigraphy. Tumori 1998;84:82-4.
27. Banzo J, Abós MD, Prats E, Delgado M, Razola P, García S, et al. La gammagrafía de receptores de somatostatina en el tumor carcinoide. Rev Esp Med Nucl 2001;20:11-8.
28. Gibril R, Doppman JL, Reynolds JC, Chen CC, Sutliff VE, Yu F, et al. Bone metastases in patients wiht gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in the detection, frequency, location, and effect of their detection on management. J Clin Oncol 1998; 16:1040-53.
29. Lebtahi R, Cadiot G, Delahaye N, Genin R, Daou D, Peker MC, et al. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. J Nucl Med 1999;40:1602-8.
30. 1-octreotide in 194 carcinoid patients: Vienna University experience, 1993 to 1998. J Clin Oncol 2000;18:1331-6.
31. Haettich B, Le Parc JM, Paolaggi JB. Les localisations osseuses des tumeurs carcinoïdes. Ann Med Interne 1989;140:383-6.
32. 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol 2003;59:565-73.